SPC365

Mortality and hospitalization costs due to heart failure associated with systemic arterial hypertension in Brazil from 2010 to 2019

Session: SESSÃO DE COMUNICAÇÕES ORAIS 03 - EPIDEMIOLOGIA E ORGANIZAÇÃO DE CUIDADOS DE SAÚDE
Speaker: Matheus de Oliveira Dutra

Congress: CPC 2025
Topic: N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
Theme: 34. Public Health and Health Economics
Subtheme: 34.3 Health Economics
Session Type: Comunicações Orais
FP Number: ---
Authors: Matheus de Oliveira Dutra; Estefanny Maria de Souza Schuck; Fátima Carolina Lopes Simões da Silva; Maria Lima de Sá; Louisie Marie Ferreira Lima; Hiochelson Najibe Dos Santos Ibiapina; Erian de Almeida Santos; Aristóteles Comte de Alencar Neto; Mônica Regina Hosannah da Silva e Silva; Bernardo Medeiros Carvalho

<p style="text-align:justify"><span style="font-size:medium"><span style="font-family:&quot;Times New Roman&quot;,serif"><span style="color:#000000"><strong><span style="font-family:Arial,sans-serif"><span style="color:black">Introduction</span></span></strong><span style="font-family:Arial,sans-serif"><span style="color:black">: Systemic arterial hypertension (SAH) represents one of the main risk factors for other cardiovascular diseases, such as heart failure (HF). In Brazil, it is estimated that more than 30% of the adult population is hypertensive and that over 2 million individuals present with HF, which is associated with a significant utilization of public health resources.</span></span></span></span></span></p>

<p style="text-align:justify"><span style="font-size:medium"><span style="font-family:&quot;Times New Roman&quot;,serif"><span style="color:#000000"><span style="font-family:Arial,sans-serif"><span style="color:black"><strong>Purpose</strong>: To describe the magnitude of mortality and hospitalizations due to heart failure (HF) associated with systemic arterial hypertension (SAH) and to evaluate the trends in expenditures related to hospital admissions for this condition across the different geographic regions of Brazil from 2010 to 2019. </span></span></span></span></span></p>

<p style="text-align:justify"><span style="font-size:medium"><span style="font-family:&quot;Times New Roman&quot;,serif"><span style="color:#000000"><span style="font-family:Arial,sans-serif"><span style="color:black"><strong>Methods</strong>: This is an ecological study on hospital admissions and mortality due to HF associated with SAH in Brazil between 2010 and 2019, using secondary data from the Hospital Information System (SIH/DATASUS) and the Mortality Information System (SIM/DATASUS), respectively. Data were filtered by category of the International Classification of Diseases (ICD-10) and analyzed in absolute and relative frequencies. The specific mortality rate was calculated per 100,000 inhabitants, based on population data from the Brazilian Institute of Geography and Statistics. Expenditures related to hospitalizations were extracted (SIH/DATASUS) and adjusted for inflation during the study period. </span></span></span></span></span></p>

<p style="text-align:justify"><span style="font-size:medium"><span style="font-family:&quot;Times New Roman&quot;,serif"><span style="color:#000000"><span style="font-family:Arial,sans-serif"><span style="color:black"><strong>Results</strong>: Between 2010 and 2019, there were 842,995 deaths due to HF, of which 35,123 (4.2%) were associated with SAH. A continuous increase in these deaths was observed during the study period, with the number of HF deaths associated with SAH rising from 2,829 in the first year to 4,327 in the last year of the time series, representing a 53.0% increase. Of the total deaths, 18,574 (52.9%) occurred in the Southeast and 7,913 (22.5%) in the Northeast. The specific mortality rate for HF associated with SAH per 100,000 inhabitants for the national territory and Brazilian regions was, respectively: Brazil (15.2), North (10.26), Northeast (14.22), Southeast (21.78), South (16.79), and Midwest (13.04). During the same period, 2,274,501 hospitalizations for HF were recorded, primarily concentrated in the Southeast, with 947,875 (41.7%). Expenditures on hospitalizations for HF totaled approximately 1.69 billion dollars, or around 742.8 dollars per admission. </span></span></span></span></span></p>

<p style="text-align:justify"><span style="font-size:medium"><span style="font-family:&quot;Times New Roman&quot;,serif"><span style="color:#000000"><span style="font-family:Arial,sans-serif"><span style="color:black"><strong>Conclusion</strong>: The increase in hospitalisations and deaths due to heart failure associated with systemic arterial hypertension in Brazil, as well as the substantial expenditures resulting from this condition, underscores the importance of prevention and control strategies to reduce fatal outcomes.</span></span></span></span></span></p>